486 completed. 486 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 486 | Completed 486 |
Follow Hematologic Diseases: new trials by email Literature Review of Hematologic Diseases trials Research Report on Hematologic Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Maternal Fatigue After Postpartum Anemia Treatment With Intravenous Ferric Carboxymaltose and Oral Iron Therapy INTRAVENOUS FERRIC CARBOXYMALTOSE, oral iron therapy - Postpartum Fatigue, Iron Deficiency Anemia | Phase 4 | Completed | Pakistan Air Force (PAF) Hospital Islamabad | 134 | 2026-04-20 | 2026-10-19 |
| Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation Asciminib - Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase | Phase 4 | Completed | Novartis Pharmaceuticals | 85 | 2024-11-28 | 2026-06-08 |
| Effects of Hydroxyurea and Metformin in Transfusion Dependent Beta-Thalassemia Tablet Metformin (Group A), Tablet Hydroxyurea (Group B) - Transfusion Dependent Beta-thalassemia | Phase 4 | Completed | Bahria University | 96 | 2024-09-16 | 2026-04-28 |
| Clinical Study of Combined Platelet Transfusion Combined platelets - Hematologic Diseases | Phase 4 | Completed | The General Hospital of Western Theater Command | 266 | 2024-08-01 | 2026-09-11 |
| Study on Pharmacokinetics of Single Injection of Ciprofol in Patients With Moderate to Severe Hypoproteinemia ciprofol - Hypoproteinemia, Pharmacokinetics | Phase 4 | Completed | Xie Kangjie | 36 | 2024-04-04 | 2025-10-01 |
| Optimizing Dosing Strategies in Oral Iron Supplementation Tardyferon - Iron Deficiencies, Iron Deficiency Anemia | Phase 4 | Completed | Luzerner Kantonsspital | 29 | 2024-03-01 | 2026-01-07 |
| BenRalizumab Effect on Airway Remodeling in Severe asTHma Benralizumab 30 mg/ml - Asthma; Eosinophilic, Airway Remodeling | Phase 4 | Completed | Aristotle University Of Thessaloniki | 36 | 2024-03-01 | 2026-10-28 |
| Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia Comparison short vs extended EBAT treatment group - Neutropenia, Febrile | Phase 4 | Completed | Universitaire Ziekenhuizen KU Leuven | 450 | 2024-02-26 | 2026-10-23 |
| Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women Iron Carboxymaltose, Iron Sucrose Injection - Iron Deficiency Anemia (IDA), Pregnancy | Phase 4 | Completed | CMH Multan Institute of Medical Sciences | 60 | 2024-02-01 | 2025-04-06 |
| The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery Bridion 200 MG in 2 ML Injection, Pyridostigmine Bromide 5 MG/ML - Emergence Delirium, Strabismus | Phase 4 | Completed | Konkuk University Medical Center | 76 | 2023-12-01 | 2026-07-15 |
| The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip Fractures Ferric carboxymaltose - Hip Fractures, Anemia | Phase 4 | Completed | Istanbul University | 209 | 2023-10-10 | 2025-03-26 |
| The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin Unfractionated heparin, Double-legged cycle ergometer exercise, Single-legged cycle ergometer exercise, with unfractionated heparin injection in the exercising leg - Blood Coagulation Disorder | Phase 4 | Completed | Kristian Karstoft | 23 | 2023-09-22 | 2024-06-26 |
| CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the Elderly Ciclosporin, Avatrombopag, Anti-Human Thymocyte Immunoglobulin, Rabbit - Aplastic Anemia | Phase 4 | Completed | Peking Union Medical College Hospital | 86 | 2023-09-15 | 2025-04-30 |
| Bridging the Healing Gap: A Single-Blind Clinical Trial Assessing the Efficacy of Carboxy-gel in Reducing Bruising and Pain Post-Liposuction Carboxytherapy, Placebo - Liposuction, Bruising | Phase 4 | Completed | Total Definer Research Group | 72 | 2023-09-01 | 2026-07-21 |
| Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients N acetyl cysteine, Placebo - Linezolid, Antioxidant | Phase 4 | Completed | Helwan University | 250 | 2023-08-01 | 2025-07-14 |
| A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease Daprodustat - Anemia, Renal Insufficiency, Chronic | Phase 4 | Completed | USRC Kidney Research | 161 | 2023-07-01 | 2024-05-24 |
| Preoperative Monoferric for Abdominal Surgery Monoferric - Anemia, Surgery | Phase 4 | Completed | Brigham and Women's Hospital | 37 | 2023-04-18 | 2026-08-26 |
| Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen to Expedite Product Availability in Perioperative Bleeding Traditional Cryoprecipitate, Pathogen-Reduced Cryoprecipitate - Hypofibrinogenemia, Bleeding | Phase 4 | Completed | Weill Medical College of Cornell University | 208 | 2023-04-01 | 2025-11-21 |
| Prevention of Cefoperazone-induced Coagulopathy Vitamin K - Antibiotic Side Effect | Phase 4 | Completed | Helwan University | 56 | 2023-02-25 | 2023-10-10 |
| A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia inotuzumab ozogamicin - Acute Lymphoblastic Leukemia | Phase 4 | Completed | Pfizer | 44 | 2023-02-24 | 2025-12-03 |
Showing 20 of 486. Sign in to see all of them.
Anemia (118) · Anemia, Iron-Deficiency (47) · Hemophilia A (38) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (30) · Multiple Myeloma (22) · Renal Insufficiency, Chronic (22) · Leukemia (20) · Leukemia, Myeloid, Acute (19) · Iron Deficiencies (18) · Neoplasms (18) · Neutropenia (18) · Anemia, Sickle Cell (17) · Myelodysplastic Syndromes (17) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (16)
Hemic and Lymphatic Diseases (486) · Pathological Conditions, Signs and Symptoms (147) · Neoplasms (130) · Pathologic Processes (123) · Neoplasms by Histologic Type (121) · Immune System Diseases (116) · Hemorrhagic Disorders (106) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (101) · Genetic Diseases, Inborn (97) · Anemia (91) · Nutritional and Metabolic Diseases (79) · Metabolic Diseases (75) · Immunoproliferative Disorders (72) · Lymphoproliferative Disorders (72)
Cytarabine (20) · ferric carboxymaltose (20) · Factor VIII (19) · Cyclophosphamide (16) · Dexamethasone (16) · Vincristine (16) · epoetin beta (16) · Darbepoetin alfa (15) · Methotrexate (15) · Epoetin Alfa (14) · ferrous sulfate (14) · Mercaptopurine (12) · Asparaginase (11) · Saline Solution (11) · continuous erythropoietin receptor activator (11)
Novartis Pharmaceuticals (27) · Hoffmann-La Roche (19) · PETHEMA Foundation (18) · Amgen (15) · Pfizer (11) · Baxalta now part of Shire (9) · Bayer (7) · Watson Pharmaceuticals (7) · Goethe University (6) · Ain Shams University (5) · AstraZeneca (5) · Institute of Hematology & Blood Diseases Hospital, China (5) · Assiut University (4) · CSL Behring (4) · GlaxoSmithKline (4)
United States (111) · China (45) · Spain (43) · Germany (39) · France (31) · United Kingdom (27) · Italy (25) · Egypt (21) · India (20) · Canada (17) · Poland (16) · Belgium (14) · Sweden (14) · Turkey (Türkiye) (13) · Switzerland (12)
Dieter Hoelzer, MD,PhD (4) · Sanz Miguel Angel, Dr (4) · Shuhua Yi, Doc (3) · Adel R. Rizkala, Pharm.D., MS (2) · Bastida Pilar, Dr (2)
PMID 36791280, PMID 18328118, PMID 34932836, PMID 36064577, PMID 41114449, PMID 18828899, PMID 19144982, PMID 19208097, PMID 22442346, PMID 22493293, PMID 23024237, PMID 24363761, PMID 24923295, PMID 26504182, PMID 27561722, PMID 27881371, PMID 28751559, PMID 28945881, PMID 12045120, PMID 14616423, PMID 14752084, PMID 15014526, PMID 15158091, PMID 15257960, PMID 15953714, PMID 16177289, PMID 16273116, PMID 16520948, PMID 16614237, PMID 16737942, PMID 16977654, PMID 17035697, PMID 17223475, PMID 17267740, PMID 17296819, PMID 17396118, PMID 17400086, PMID 17470691, PMID 17522247, PMID 17621407, PMID 17622274, PMID 17694552, PMID 17962803, PMID 18008242, PMID 18056840, PMID 18067679, PMID 18165618, PMID 18216316, PMID 18284320, PMID 18343652
2009 (8), 2014 (4), 2015 (4), 2016 (4), 2018 (4), 2005 (3), 2008 (3), 2019 (3), 2017 (2), 2023 (2), 2004 (1), P30AI060354 (1), P30CA021765 (1), R01CA078957 (1), R01CA091912 (1)